CHICAGO (AP) — CHICAGO (AP) — Xeris Biopharma Holdings, Inc. (XERS) on Thursday reported third-quarter profit of $11.3 million.

On a per-share basis, the Chicago-based company said it had profit of 6 cents.

The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 2 cents per share.

The company posted revenue of $107.2 million in the period, which also topped Street forecasts. Three analysts surveyed by Zacks expected $101 million.

Xeris Biopharma expects full-year revenue in the range of $395 million to $405 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on XERS at https://www.zacks.com/ap/XERS